世界のデシタビンAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Decitabine API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1079 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はデシタビンAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。デシタビンAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（デシタビン注射、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・デシタビンAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・デシタビンAPIの種類別市場規模：純度≥98％、純度<98％ ・デシタビンAPIの用途別市場規模：デシタビン注射、その他 ・北米のデシタビンAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのデシタビンAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのデシタビンAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のデシタビンAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのデシタビンAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、Biophore India Pharmaceuticals、Tecoland Corporation、Johnson Matthey PLC、Farmhispania, S.A.、VShilpa Medicare Limitedbshilpa、Wuhan Calmland Pharmaceuticals Co.,Ltd、ScinoPharm Taiwan, Ltd、Zhejiang Hisun Pharmaceutical、Mac-Chem Products (India) Pvt.Ltd、Synthland Limited、Hanways Chempharm Co., Limited ・デシタビンAPIのバリューチェーン・販売チャネル分析 ・デシタビンAPIの世界市場動向

Decitabine is a cytosine analogue and an intravenously administered antineoplastic agent used in the therapy of myelodysplastic syndromes. Decitabine is associated with a low rate of transient serum enzyme elevations during therapy, but has not been implicated in causing clinically apparent liver injury with jaundice.

Market Analysis and Insights: Global Decitabine API Market
The global Decitabine API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Decitabine API Scope and Segment
Decitabine API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Decitabine API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Decitabine Injections Others By Company Dr. Reddy’s Laboratories Ltd. Biophore India Pharmaceuticals Tecoland Corporation Johnson Matthey PLC Farmhispania, S.A. VShilpa Medicare Limitedbshilpa Wuhan Calmland Pharmaceuticals Co.,Ltd ScinoPharm Taiwan, Ltd Zhejiang Hisun Pharmaceutical Mac-Chem Products (India) Pvt.Ltd Synthland Limited Hanways Chempharm Co., Limited Production by Region North America Europe China China Taiwan India Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Decitabine API Product Introduction
1.2 Market by Type
1.2.1 Global Decitabine API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Decitabine API Market Size Growth Rate by Application 1.3.2 Decitabine Injections 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Decitabine API Production 2.1 Global Decitabine API Production Capacity (2016-2027) 2.2 Global Decitabine API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Decitabine API Production by Region 2.3.1 Global Decitabine API Historic Production by Region (2016-2021) 2.3.2 Global Decitabine API Forecasted Production by Region (2022-2027) 2.4 North America 2.5 Europe 2.6 China 2.7 China Taiwan 2.8 India 3 Global Decitabine API Sales in Volume & Value Estimates and Forecasts 3.1 Global Decitabine API Sales Estimates and Forecasts 2016-2027 3.2 Global Decitabine API Revenue Estimates and Forecasts 2016-2027 3.3 Global Decitabine API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Decitabine API Regions by Sales 3.4.1 Global Top Decitabine API Regions by Sales (2016-2021) 3.4.2 Global Top Decitabine API Regions by Sales (2022-2027) 3.5 Global Top Decitabine API Regions by Revenue 3.5.1 Global Top Decitabine API Regions by Revenue (2016-2021) 3.5.2 Global Top Decitabine API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Decitabine API Production Capacity by Manufacturers 4.2 Global Decitabine API Sales by Manufacturers 4.2.1 Global Top Decitabine API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Decitabine API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Decitabine API Sales in 2020 4.3 Global Decitabine API Revenue by Manufacturers 4.3.1 Global Top Decitabine API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Decitabine API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Decitabine API Revenue in 2020 4.4 Global Decitabine API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Decitabine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Decitabine API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Decitabine API Sales by Type 5.1.1 Global Decitabine API Historical Sales by Type (2016-2021) 5.1.2 Global Decitabine API Forecasted Sales by Type (2022-2027) 5.1.3 Global Decitabine API Sales Market Share by Type (2016-2027) 5.2 Global Decitabine API Revenue by Type 5.2.1 Global Decitabine API Historical Revenue by Type (2016-2021) 5.2.2 Global Decitabine API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Decitabine API Revenue Market Share by Type (2016-2027) 5.3 Global Decitabine API Price by Type 5.3.1 Global Decitabine API Price by Type (2016-2021) 5.3.2 Global Decitabine API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Decitabine API Sales by Application 6.1.1 Global Decitabine API Historical Sales by Application (2016-2021) 6.1.2 Global Decitabine API Forecasted Sales by Application (2022-2027) 6.1.3 Global Decitabine API Sales Market Share by Application (2016-2027) 6.2 Global Decitabine API Revenue by Application 6.2.1 Global Decitabine API Historical Revenue by Application (2016-2021) 6.2.2 Global Decitabine API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Decitabine API Revenue Market Share by Application (2016-2027) 6.3 Global Decitabine API Price by Application 6.3.1 Global Decitabine API Price by Application (2016-2021) 6.3.2 Global Decitabine API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Decitabine API Market Size by Type 7.1.1 North America Decitabine API Sales by Type (2016-2027) 7.1.2 North America Decitabine API Revenue by Type (2016-2027) 7.2 North America Decitabine API Market Size by Application 7.2.1 North America Decitabine API Sales by Application (2016-2027) 7.2.2 North America Decitabine API Revenue by Application (2016-2027) 7.3 North America Decitabine API Sales by Country 7.3.1 North America Decitabine API Sales by Country (2016-2027) 7.3.2 North America Decitabine API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Decitabine API Market Size by Type 8.1.1 Europe Decitabine API Sales by Type (2016-2027) 8.1.2 Europe Decitabine API Revenue by Type (2016-2027) 8.2 Europe Decitabine API Market Size by Application 8.2.1 Europe Decitabine API Sales by Application (2016-2027) 8.2.2 Europe Decitabine API Revenue by Application (2016-2027) 8.3 Europe Decitabine API Sales by Country 8.3.1 Europe Decitabine API Sales by Country (2016-2027) 8.3.2 Europe Decitabine API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Decitabine API Market Size by Type 9.1.1 Asia Pacific Decitabine API Sales by Type (2016-2027) 9.1.2 Asia Pacific Decitabine API Revenue by Type (2016-2027) 9.2 Asia Pacific Decitabine API Market Size by Application 9.2.1 Asia Pacific Decitabine API Sales by Application (2016-2027) 9.2.2 Asia Pacific Decitabine API Revenue by Application (2016-2027) 9.3 Asia Pacific Decitabine API Sales by Region 9.3.1 Asia Pacific Decitabine API Sales by Region (2016-2027) 9.3.2 Asia Pacific Decitabine API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Decitabine API Market Size by Type 10.1.1 Latin America Decitabine API Sales by Type (2016-2027) 10.1.2 Latin America Decitabine API Revenue by Type (2016-2027) 10.2 Latin America Decitabine API Market Size by Application 10.2.1 Latin America Decitabine API Sales by Application (2016-2027) 10.2.2 Latin America Decitabine API Revenue by Application (2016-2027) 10.3 Latin America Decitabine API Sales by Country 10.3.1 Latin America Decitabine API Sales by Country (2016-2027) 10.3.2 Latin America Decitabine API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Decitabine API Market Size by Type 11.1.1 Middle East and Africa Decitabine API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Decitabine API Revenue by Type (2016-2027) 11.2 Middle East and Africa Decitabine API Market Size by Application 11.2.1 Middle East and Africa Decitabine API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Decitabine API Revenue by Application (2016-2027) 11.3 Middle East and Africa Decitabine API Sales by Country 11.3.1 Middle East and Africa Decitabine API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Decitabine API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Decitabine API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Biophore India Pharmaceuticals 12.2.1 Biophore India Pharmaceuticals Corporation Information 12.2.2 Biophore India Pharmaceuticals Overview 12.2.3 Biophore India Pharmaceuticals Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Biophore India Pharmaceuticals Decitabine API Product Description 12.2.5 Biophore India Pharmaceuticals Recent Developments 12.3 Tecoland Corporation 12.3.1 Tecoland Corporation Corporation Information 12.3.2 Tecoland Corporation Overview 12.3.3 Tecoland Corporation Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Tecoland Corporation Decitabine API Product Description 12.3.5 Tecoland Corporation Recent Developments 12.4 Johnson Matthey PLC 12.4.1 Johnson Matthey PLC Corporation Information 12.4.2 Johnson Matthey PLC Overview 12.4.3 Johnson Matthey PLC Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Johnson Matthey PLC Decitabine API Product Description 12.4.5 Johnson Matthey PLC Recent Developments 12.5 Farmhispania, S.A. 12.5.1 Farmhispania, S.A. Corporation Information 12.5.2 Farmhispania, S.A. Overview 12.5.3 Farmhispania, S.A. Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Farmhispania, S.A. Decitabine API Product Description 12.5.5 Farmhispania, S.A. Recent Developments 12.6 VShilpa Medicare Limitedbshilpa 12.6.1 VShilpa Medicare Limitedbshilpa Corporation Information 12.6.2 VShilpa Medicare Limitedbshilpa Overview 12.6.3 VShilpa Medicare Limitedbshilpa Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 VShilpa Medicare Limitedbshilpa Decitabine API Product Description 12.6.5 VShilpa Medicare Limitedbshilpa Recent Developments 12.7 Wuhan Calmland Pharmaceuticals Co.,Ltd 12.7.1 Wuhan Calmland Pharmaceuticals Co.,Ltd Corporation Information 12.7.2 Wuhan Calmland Pharmaceuticals Co.,Ltd Overview 12.7.3 Wuhan Calmland Pharmaceuticals Co.,Ltd Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Wuhan Calmland Pharmaceuticals Co.,Ltd Decitabine API Product Description 12.7.5 Wuhan Calmland Pharmaceuticals Co.,Ltd Recent Developments 12.8 ScinoPharm Taiwan, Ltd 12.8.1 ScinoPharm Taiwan, Ltd Corporation Information 12.8.2 ScinoPharm Taiwan, Ltd Overview 12.8.3 ScinoPharm Taiwan, Ltd Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 ScinoPharm Taiwan, Ltd Decitabine API Product Description 12.8.5 ScinoPharm Taiwan, Ltd Recent Developments 12.9 Zhejiang Hisun Pharmaceutical 12.9.1 Zhejiang Hisun Pharmaceutical Corporation Information 12.9.2 Zhejiang Hisun Pharmaceutical Overview 12.9.3 Zhejiang Hisun Pharmaceutical Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 Zhejiang Hisun Pharmaceutical Decitabine API Product Description 12.9.5 Zhejiang Hisun Pharmaceutical Recent Developments 12.10 Mac-Chem Products (India) Pvt.Ltd 12.10.1 Mac-Chem Products (India) Pvt.Ltd Corporation Information 12.10.2 Mac-Chem Products (India) Pvt.Ltd Overview 12.10.3 Mac-Chem Products (India) Pvt.Ltd Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Mac-Chem Products (India) Pvt.Ltd Decitabine API Product Description 12.10.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments 12.11 Synthland Limited 12.11.1 Synthland Limited Corporation Information 12.11.2 Synthland Limited Overview 12.11.3 Synthland Limited Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.11.4 Synthland Limited Decitabine API Product Description 12.11.5 Synthland Limited Recent Developments 12.12 Hanways Chempharm Co., Limited 12.12.1 Hanways Chempharm Co., Limited Corporation Information 12.12.2 Hanways Chempharm Co., Limited Overview 12.12.3 Hanways Chempharm Co., Limited Decitabine API Sales, Price, Revenue and Gross Margin (2016-2021) 12.12.4 Hanways Chempharm Co., Limited Decitabine API Product Description 12.12.5 Hanways Chempharm Co., Limited Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Decitabine API Industry Chain Analysis 13.2 Decitabine API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Decitabine API Production Mode & Process 13.4 Decitabine API Sales and Marketing 13.4.1 Decitabine API Sales Channels 13.4.2 Decitabine API Distributors 13.5 Decitabine API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Decitabine API Industry Trends 14.2 Decitabine API Market Drivers 14.3 Decitabine API Market Challenges 14.4 Decitabine API Market Restraints 15 Key Finding in The Global Decitabine API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Decitabine API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Decitabine API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Decitabine API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Decitabine API Production by Region (2016-2021) & (Ton)
Table 7. Global Decitabine API Production Market Share by Region (2016-2021)
Table 8. Global Decitabine API Production by Region (2022-2027) & (Ton)
Table 9. Global Decitabine API Production Market Share by Region (2022-2027)
Table 10. Global Decitabine API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Decitabine API Sales by Region (2016-2021) & (Ton)
Table 12. Global Decitabine API Sales Market Share by Region (2016-2021)
Table 13. Global Decitabine API Sales by Region (2022-2027) & (Ton)
Table 14. Global Decitabine API Sales Market Share by Region (2022-2027)
Table 15. Global Decitabine API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Decitabine API Revenue Market Share by Region (2016-2021)
Table 17. Global Decitabine API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Decitabine API Revenue Market Share by Region (2022-2027)
Table 19. Global Decitabine API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Decitabine API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Decitabine API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Decitabine API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Decitabine API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Decitabine API Sales Share by Manufacturers (2016-2021)
Table 25. Global Decitabine API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Decitabine API Revenue Share by Manufacturers (2016-2021)
Table 27. Decitabine API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Decitabine API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Decitabine API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decitabine API as of 2020)
Table 30. Decitabine API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Decitabine API Product Offered
Table 32. Date of Manufacturers Enter into Decitabine API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Decitabine API Sales by Type (2016-2021) & (Ton)
Table 35. Global Decitabine API Sales by Type (2022-2027) & (Ton)
Table 36. Global Decitabine API Sales Share by Type (2016-2021)
Table 37. Global Decitabine API Sales Share by Type (2022-2027)
Table 38. Global Decitabine API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Decitabine API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Decitabine API Revenue Share by Type (2016-2021)
Table 41. Global Decitabine API Revenue Share by Type (2022-2027)
Table 42. Decitabine API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Decitabine API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Decitabine API Sales by Application (2016-2021) & (Ton)
Table 45. Global Decitabine API Sales by Application (2022-2027) & (Ton)
Table 46. Global Decitabine API Sales Share by Application (2016-2021)
Table 47. Global Decitabine API Sales Share by Application (2022-2027)
Table 48. Global Decitabine API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Decitabine API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Decitabine API Revenue Share by Application (2016-2021)
Table 51. Global Decitabine API Revenue Share by Application (2022-2027)
Table 52. Decitabine API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Decitabine API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Decitabine API Sales by Type (2016-2021) & (Ton)
Table 55. North America Decitabine API Sales by Type (2022-2027) & (Ton)
Table 56. North America Decitabine API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Decitabine API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Decitabine API Sales by Application (2016-2021) & (Ton)
Table 59. North America Decitabine API Sales by Application (2022-2027) & (Ton)
Table 60. North America Decitabine API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Decitabine API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Decitabine API Sales by Country (2016-2021) & (Ton)
Table 63. North America Decitabine API Sales by Country (2022-2027) & (Ton)
Table 64. North America Decitabine API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Decitabine API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Decitabine API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Decitabine API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Decitabine API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Decitabine API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Decitabine API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Decitabine API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Decitabine API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Decitabine API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Decitabine API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Decitabine API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Decitabine API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Decitabine API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Decitabine API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Decitabine API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Decitabine API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Decitabine API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Decitabine API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Decitabine API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Decitabine API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Decitabine API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Decitabine API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Decitabine API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Decitabine API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Decitabine API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Decitabine API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Decitabine API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Decitabine API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Decitabine API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Decitabine API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Decitabine API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Decitabine API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Decitabine API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Decitabine API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Decitabine API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Decitabine API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Decitabine API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Decitabine API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Decitabine API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Decitabine API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Decitabine API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Decitabine API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Decitabine API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Decitabine API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Decitabine API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Decitabine API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Decitabine API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Decitabine API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Decitabine API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Decitabine API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Biophore India Pharmaceuticals Corporation Information
Table 120. Biophore India Pharmaceuticals Description and Major Businesses
Table 121. Biophore India Pharmaceuticals Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Biophore India Pharmaceuticals Decitabine API Product
Table 123. Biophore India Pharmaceuticals Recent Development
Table 124. Tecoland Corporation Corporation Information
Table 125. Tecoland Corporation Description and Major Businesses
Table 126. Tecoland Corporation Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Tecoland Corporation Decitabine API Product
Table 128. Tecoland Corporation Recent Development
Table 129. Johnson Matthey PLC Corporation Information
Table 130. Johnson Matthey PLC Description and Major Businesses
Table 131. Johnson Matthey PLC Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Johnson Matthey PLC Decitabine API Product
Table 133. Johnson Matthey PLC Recent Development
Table 134. Farmhispania, S.A. Corporation Information
Table 135. Farmhispania, S.A. Description and Major Businesses
Table 136. Farmhispania, S.A. Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Farmhispania, S.A. Decitabine API Product
Table 138. Farmhispania, S.A. Recent Development
Table 139. VShilpa Medicare Limitedbshilpa Corporation Information
Table 140. VShilpa Medicare Limitedbshilpa Description and Major Businesses
Table 141. VShilpa Medicare Limitedbshilpa Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. VShilpa Medicare Limitedbshilpa Decitabine API Product
Table 143. VShilpa Medicare Limitedbshilpa Recent Development
Table 144. Wuhan Calmland Pharmaceuticals Co.,Ltd Corporation Information
Table 145. Wuhan Calmland Pharmaceuticals Co.,Ltd Description and Major Businesses
Table 146. Wuhan Calmland Pharmaceuticals Co.,Ltd Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Wuhan Calmland Pharmaceuticals Co.,Ltd Decitabine API Product
Table 148. Wuhan Calmland Pharmaceuticals Co.,Ltd Recent Development
Table 149. ScinoPharm Taiwan, Ltd Corporation Information
Table 150. ScinoPharm Taiwan, Ltd Description and Major Businesses
Table 151. ScinoPharm Taiwan, Ltd Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. ScinoPharm Taiwan, Ltd Decitabine API Product
Table 153. ScinoPharm Taiwan, Ltd Recent Development
Table 154. Zhejiang Hisun Pharmaceutical Corporation Information
Table 155. Zhejiang Hisun Pharmaceutical Description and Major Businesses
Table 156. Zhejiang Hisun Pharmaceutical Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. Zhejiang Hisun Pharmaceutical Decitabine API Product
Table 158. Zhejiang Hisun Pharmaceutical Recent Development
Table 159. Mac-Chem Products (India) Pvt.Ltd Corporation Information
Table 160. Mac-Chem Products (India) Pvt.Ltd Description and Major Businesses
Table 161. Mac-Chem Products (India) Pvt.Ltd Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Mac-Chem Products (India) Pvt.Ltd Decitabine API Product
Table 163. Mac-Chem Products (India) Pvt.Ltd Recent Development
Table 164. Synthland Limited Corporation Information
Table 165. Synthland Limited Description and Major Businesses
Table 166. Synthland Limited Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 167. Synthland Limited Decitabine API Product
Table 168. Synthland Limited Recent Development
Table 169. Hanways Chempharm Co., Limited Corporation Information
Table 170. Hanways Chempharm Co., Limited Description and Major Businesses
Table 171. Hanways Chempharm Co., Limited Decitabine API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 172. Hanways Chempharm Co., Limited Decitabine API Product
Table 173. Hanways Chempharm Co., Limited Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Decitabine API Distributors List
Table 177. Decitabine API Customers List
Table 178. Decitabine API Market Trends
Table 179. Decitabine API Market Drivers
Table 180. Decitabine API Market Challenges
Table 181. Decitabine API Market Restraints
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Decitabine API Product Picture
Figure 2. Global Decitabine API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Decitabine API Market Share by Application in 2020 & 2027
Figure 6. Decitabine Injections
Figure 7. Others
Figure 8. Decitabine API Report Years Considered
Figure 9. Global Decitabine API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Decitabine API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Decitabine API Production Market Share by Region (2016-2021)
Figure 12. Global Decitabine API Production Market Share by Region (2022-2027)
Figure 13. Decitabine API Production Growth Rate in North America (2016-2027) & (Ton)
Figure 14. Decitabine API Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Decitabine API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Decitabine API Production Growth Rate in China Taiwan (2016-2027) & (Ton)
Figure 17. Decitabine API Production Growth Rate in India (2016-2027) & (Ton)
Figure 18. Global Decitabine API Sales 2016-2027 (Ton)
Figure 19. Global Decitabine API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Decitabine API Revenue 2016-2027 (US$ Million)
Figure 21. Global Decitabine API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 22. Global Decitabine API Sales Market Share by Region (2016-2021)
Figure 23. Global Decitabine API Sales Market Share by Region (2022-2027)
Figure 24. North America Decitabine API Sales YoY (2016-2027) & (Ton)
Figure 25. North America Decitabine API Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Europe Decitabine API Sales YoY (2016-2027) & (Ton)
Figure 27. Europe Decitabine API Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Asia-Pacific Decitabine API Sales YoY (2016-2027) & (Ton)
Figure 29. Asia-Pacific Decitabine API Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Latin America Decitabine API Sales YoY (2016-2027) & (Ton)
Figure 31. Latin America Decitabine API Revenue YoY (2016-2027) & (US$ Million)
Figure 32. Middle East & Africa Decitabine API Sales YoY (2016-2027) & (Ton)
Figure 33. Middle East & Africa Decitabine API Revenue YoY (2016-2027) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Decitabine API Sales in 2020
Figure 35. The Top 10 and Top 5 Players Market Share by Decitabine API Revenue in 2020
Figure 36. Decitabine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 37. Global Decitabine API Sales Market Share by Type (2016-2027)
Figure 38. Global Decitabine API Revenue Market Share by Type (2016-2027)
Figure 39. Global Decitabine API Sales Market Share by Application (2016-2027)
Figure 40. Global Decitabine API Revenue Market Share by Application (2016-2027)
Figure 41. North America Decitabine API Sales Market Share by Type (2016-2027)
Figure 42. North America Decitabine API Revenue Market Share by Type (2016-2027)
Figure 43. North America Decitabine API Sales Market Share by Application (2016-2027)
Figure 44. North America Decitabine API Revenue Market Share by Application (2016-2027)
Figure 45. North America Decitabine API Sales Share by Country (2016-2027)
Figure 46. North America Decitabine API Revenue Share by Country (2016-2027)
Figure 47. United States Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 48. Canada Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 49. Europe Decitabine API Sales Market Share by Type (2016-2027)
Figure 50. Europe Decitabine API Revenue Market Share by Type (2016-2027)
Figure 51. Europe Decitabine API Sales Market Share by Application (2016-2027)
Figure 52. Europe Decitabine API Revenue Market Share by Application (2016-2027)
Figure 53. Europe Decitabine API Sales Share by Country (2016-2027)
Figure 54. Europe Decitabine API Revenue Share by Country (2016-2027)
Figure 55. Germany Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 56. France Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 57. U.K. Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 58. Italy Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 59. Russia Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 60. Asia Pacific Decitabine API Sales Market Share by Type (2016-2027)
Figure 61. Asia Pacific Decitabine API Revenue Market Share by Type (2016-2027)
Figure 62. Asia Pacific Decitabine API Sales Market Share by Application (2016-2027)
Figure 63. Asia Pacific Decitabine API Revenue Market Share by Application (2016-2027)
Figure 64. Asia Pacific Decitabine API Sales Share by Region (2016-2027)
Figure 65. Asia Pacific Decitabine API Revenue Share by Region (2016-2027)
Figure 66. China Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 67. Japan Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 68. South Korea Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 69. India Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 70. Australia Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 71. China Taiwan Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 72. Indonesia Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 73. Thailand Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 74. Malaysia Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 75. Latin America Decitabine API Sales Market Share by Type (2016-2027)
Figure 76. Latin America Decitabine API Revenue Market Share by Type (2016-2027)
Figure 77. Latin America Decitabine API Sales Market Share by Application (2016-2027)
Figure 78. Latin America Decitabine API Revenue Market Share by Application (2016-2027)
Figure 79. Latin America Decitabine API Sales Share by Country (2016-2027)
Figure 80. Latin America Decitabine API Revenue Share by Country (2016-2027)
Figure 81. Mexico Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 82. Brazil Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 83. Argentina Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 84. Middle East and Africa Decitabine API Sales Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Decitabine API Revenue Market Share by Type (2016-2027)
Figure 86. Middle East and Africa Decitabine API Sales Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Decitabine API Revenue Market Share by Application (2016-2027)
Figure 88. Middle East and Africa Decitabine API Sales Share by Country (2016-2027)
Figure 89. Middle East and Africa Decitabine API Revenue Share by Country (2016-2027)
Figure 90. Turkey Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 91. Saudi Arabia Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 92. UAE Decitabine API Revenue (2016-2027) & (US$ Million)
Figure 93. Decitabine API Value Chain
Figure 94. Decitabine API Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

---